Sphingosine kinase inhibitors in the apoptosis of leukaemia cells.
Pallis
Monica
M
Academic Haematology, Clinical Sciences Building, City Hospital, Nottingham, UK.
D017209:Apoptosis / Q000187:drug effects*; D004791:Enzyme Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology*; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000037:antagonists & inhibitors*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D000099157:Sphingosine Kinase
D004791:Enzyme Inhibitors; D017853:Phosphotransferases (Alcohol Group Acceptor); D013110:Sphingosine; D000099157:Sphingosine Kinase; C071600:N,N,N-trimethylsphingosine; C061800:N,N-dimethylsphingosine